Treatment Failure of Botulinum Toxin A in Patients with Idiopathic Overactive Bladder: Why Do Patients Discontinue Treatment?


Objectives: The study aimed to evaluate the long-term compliance and reasons for discontinuation of intravesical botulinum toxin A (BoNT-A) treatment in women with idiopathic overactive bladder syndrome (iOAB). Methods: All patients who had been treated with BoNT-A between 2004 and 2010 were invited to join a written survey in June, 2015. Only women with… (More)


4 Figures and Tables